Select a Program at Montefiore Medical Center CLINICAL SERVICES • Advanced Imaging at Montefiore • Allergy and Immunology • Centers of Excellence • Clinical Diabetes Center • Cough Center • Dentistry • Dermatology • Emergency Medicine • Family and Social Medicine • Gastroenterology • Geriatrics • Headache Center • Hematology • Home Health Care • Infectious Diseases • Montefiore Medical Group • Montefiore Medical Specialists • Nephrology • Neurology • Neuromuscular Disease • Nuclear Medicine • Pathology • Psychiatry and Behavioral Sciences • Pulmonary Medicine • Rheumatology • Sleep-Wake Disorders Center MONTEFIORE-EINSTEIN CANCER CENTER • Breast Cancer • Clinical Trials • Colorectal Cancer • Gastrointestinal Oncology • Gynecologic Oncology • Head & Neck Cancer Program • Lung Cancer • Prevention and Support • Radiation Oncology • Robotic Prostate Surgery • Sarcoma and Connective Tissue Oncology Center • Surgical Oncology • Translational Research • Urological Oncology CHILDREN'S HOSPITAL AT MONTEFIORE WOMEN'S HEALTH AT MONTEFIORE • Childbirth • Family Planning & Birth Control • Fibroid Center • Genetic Counseling Services • Group Prenatal Care • High-Risk Pregnancy (Maternal-Fetal Medicine) • Infertility - Dine with the Experts • Infertility – Assisted Reproductive Technologies Program • Menopause & Aging — General Health • Menopause & Aging: Hormone Replacement & Bone Health • Montefiore Institute for Reproductive Medicine and Health ... • Obstetrics Gynecology & Wellness • Preconceptual Counseling and Testing • Reproductive Genetics and Prenatal Genetic Testing • Urogynecology SURGERY AT MONTEFIORE • Head and Neck Surgery • Montefiore Institute for Minimally Invasive Surgery • Neurological Surgery • Ophthalmology and Visual Science • Oral and Maxillofacial Surgery • Orthopaedic Surgery • Otorhinolaryngology - Head and Neck Surgery • Plastic & Reconstructive Surgery • Urological Disorders • Vascular Disease Management • Weight Reduction Surgery

Current Clinical Trials

Clinical Trial for a New Acute Treatment for Migraine

We are seeking patients with 1 to 8 days of migraine headaches per month and who currently treat their migraines with Fioricet® and/or other butalbital-containing combination medications (BCM) to participate in a research study evaluating Trexima^TM, a new investigational medication for the acute treatment of migraine. BCMs and other barbiturates are among the most commonly prescribed medications for the treatment of migraine headaches; however, they are often associated with many serious and undesirable side effects. Participants in this study will be asked to treat 3 separate migraine attacks within a 19 week period with one of three study medications: Trexima^TM, a BCM, or placebo. Qualified participants will receive all study-related care at no charge. Reimbursement for time and travel may also be available.

For more information, please contact our research coordinators at (718) 405-8007. Principal Investigator: Brian Grosberg, MD; IRB#: 07-02-268-01; IRB approved through 2/13/2009.

 

Clinical Trial for a New Preventive Treatment for Migraine

We are seeking patients with 3 to 12 days of migraine headaches per month to participate in a research study to test the effectiveness of Tonabersat (SB-220453), the first drug specifically designed to prevent migraine headaches. Currently, all of the medications used for the prevention of migraine were developed to treat other conditions such as high blood pressure, epilepsy or depression. In order to properly measure the effects of Tonabersat, patients will be randomly assigned to one of three treatment groups. This study will be conducted over 20 weeks with up to 7 clinic visits. At the end of the study it will be possible for patients to enter a longer study in which all patients will receive Tonabersat. Qualified participants will receive all study-related care at no charge. Reimbursement for time and travel may also be available.

For more information, please contact our research coordinators at (718) 405-8007. Principal Investigator: Brian Grosberg, MD; IRB#: 07-02-140-01; IRB approved through 7/4/2008.

Our Services

For New Patients

Physicians and Staff

Current Clinical Trials

Resources

Contact Us